David K. Morris - 28 Mar 2026 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Signature
/s/ Douglas Towns, Attorney-in-Fact
Issuer symbol
GRDN
Transactions as of
28 Mar 2026
Net transactions value
$0
Form type
4
Filing time
31 Mar 2026, 16:05:08 UTC
Previous filing
24 Mar 2026

Sponsored

Quoteable Key Fact

"David K. Morris filed Form 4 for Guardian Pharmacy Services, Inc. (GRDN) on 31 Mar 2026."

Quick Takeaways

  • This page summarizes David K. Morris's Form 4 filing for Guardian Pharmacy Services, Inc. (GRDN).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 31 Mar 2026, 16:05.

What Changed

  • Previous filing in this sequence was filed on 24 Mar 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morris David K Executive Vice President and Chief Financial Officer, Director 300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA /s/ Douglas Towns, Attorney-in-Fact 31 Mar 2026 0002037977

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRDN Class A Common Stock Options Exercise +641,869 +252% 896,341 28 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRDN Class B Common Stock Options Exercise -641,869 -50% 641,870 28 Mar 2026 Class A Common Stock 641,869 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, in substantially equal tranches on each of March 28, 2026 and September 27, 2026.

Remarks:

Executive Vice President and Chief Financial Officer